Key result
Circulating thrombopoietin levels in ITP patients were mildly elevated compared to normal subjects but much lower than in aplastic anemia.
Why the study?
Are circulating thrombopoietin levels elevated in patients with chronic immune thrombocytopenic purpura compared to normal subjects and those with aplastic anaemia?
Observational (n=43)
Are circulating thrombopoietin levels elevated in patients with chronic immune thrombocytopenic purpura compared to normal subjects and those with aplastic anaemia?
Relative endogenous TPO deficiency may play a role in the pathophysiology of thrombocytopenia in ITP patients, as their TPO levels are only mildly elevated compared to the massive increase seen in aplastic anemia.
Answers are grounded in this paper and cite their sources.
May support relative TPO deficiency in ITP thrombocytopenia; hypothesis-generating for TPO agonists in chronic disease.
The circulating thrombopoietin (TPO) level in 43 patients with chronic immune thrombocytopenic purpura (ITP) was examined by an ELISA system. The TPO level (mean +/- SD) in ITP patients was mildly elevated (1.86 +/- 1.17 fmol/ml) compared to that in normal subjects (0.76 +/- 0.21), and was within the normal range in 30% of ITP patients. In contrast, the TPO level in patients with aplastic anaemia was very high, 12.35 +/- 6.42 fmol/ml. There was no correlation between TPO level and platelet count in ITP patients. Splenectomy was performed in two ITP patients, after which platelet counts increased to normal levels and TPO levels showed a transient increase. These data suggest that reactive TPO production against thrombocytopenia in ITP is small when compared to that in aplastic anaemia. Relative endogenous TPO deficiency may play some role in the pathophysiology of thrombocytopenia in ITP patients.
No takes yet. Share an insight, caveat, or question.
Kosugi et al. (1996) conducted an observational in Chronic immune thrombocytopenic purpura (ITP) (n=43). Circulating thrombopoietin (TPO) level measurement vs. Normal subjects and patients with aplastic anaemia was evaluated on Circulating thrombopoietin (TPO) level. Circulating thrombopoietin levels in ITP patients were mildly elevated compared to normal subjects but much lower than in aplastic anemia.
Synapse has enriched 10 related papers. Consider them for comparative context: